Overview

Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Pharmacokinetics, safety and wearability in two size patches of AG890 over eight weeks will be evaluated.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Agile Therapeutics
Treatments:
Contraceptive Agents
Levonorgestrel
Progestins